Document Detail


Relapsing vivax malaria after 6 months of daily atovaquone/proguanil in Afghanistan: the case for expanded use of primaquine as a causal prophylactic.
MedLine Citation:
PMID:  17995538     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 22-year-old soldier presented with vivax malaria after extended travel in Afghanistan. Compliant with atovaquone/proguanil in country, he discontinued prophylaxis immediately upon departure. This case raises important issues regarding prophylactic choice and compliance during travel to Plasmodium vivax endemic locations and primaquine's registration status for prophylaxis and use by practitioners.
Authors:
Jason D Maguire; David M Llewellyn
Related Documents :
15855468 - Tuberculosis among american indians and alaska natives in the united states, 1993-2002.
17553228 - Risk factors for imported fatal plasmodium falciparum malaria, france, 1996-2003.
12757048 - Public-private mix for improved tb control in ho chi minh city, vietnam: an assessment ...
16779468 - Bronchoscopic management of airway obstruction in pediatric endobronchial tuberculosis.
10197808 - Fatal outcome due to cyclosporine neurotoxicity with associated pathological findings.
3903858 - Uterine perforation and embedding by intrauterine device: evaluation by us and hysterog...
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Journal of travel medicine     Volume:  14     ISSN:  1195-1982     ISO Abbreviation:  J Travel Med     Publication Date:    2007 Nov-Dec
Date Detail:
Created Date:  2007-11-12     Completed Date:  2008-02-21     Revised Date:  2009-07-07    
Medline Journal Info:
Nlm Unique ID:  9434456     Medline TA:  J Travel Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  411-4     Citation Subset:  IM    
Affiliation:
U.S. Military Hospital, Expeditionary Medical Facility, Arifjan, Kuwait. jason.maguire@med.navy.mil
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Afghanistan
Antimalarials / administration & dosage*
Atovaquone / administration & dosage
Chloroguanide / administration & dosage
Drug Therapy, Combination
Humans
Malaria, Vivax / prevention & control*
Male
Mefloquine / administration & dosage
Military Personnel
Patient Compliance
Primaquine / administration & dosage
Recurrence
Travel
Chemical
Reg. No./Substance:
0/Antimalarials; 500-92-5/Chloroguanide; 53230-10-7/Mefloquine; 90-34-6/Primaquine; 94015-53-9/Atovaquone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Eosinophilic meningitis in a returned traveler from Santo Domingo: case report and review.
Next Document:  Assessing the value of the NHIS for studying changes in state coverage policies: the case of New Yor...